Cart
sales@molnova.com
HT-0712
CAS No. 617720-02-2
HT-0712 ( IPL-455903 )
Catalog No. M15336 CAS No. 617720-02-2
HT-0712 (IPL-455903) is a novel potent, selective PDE4 inhibitor with IC50 of 0.15 uM for PDE4D3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1053 | Get Quote |
|
| 50MG | 2142 | Get Quote |
|
| 100MG | 2790 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHT-0712
-
NoteResearch use only, not for human use.
-
Brief DescriptionHT-0712 (IPL-455903) is a novel potent, selective PDE4 inhibitor with IC50 of 0.15 uM for PDE4D3.
-
DescriptionHT-0712 (IPL-455903) is a novel potent, selective PDE4 inhibitor with IC50 of 0.15 uM for PDE4D3, without effect on PDE1B, PDE3A, and PDE10A; facilitates expression of a CRE-luciferase reporter gene and expression of the CREB target-gene somatostatin in SK-N-MC neuroblastoma cells, abolishes the long-term memory defect of CBP+/- mice, enhances long-term memory formation in normal young mice at brain concentrations similar to those found to increase CRE-mediated gene expression in hippocampal neurons.Alzheimer Disease Phase 2 Clinical
-
SynonymsIPL-455903
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaNeurological Disease
-
IndicationAlzheimer Disease
Chemical Information
-
CAS Number617720-02-2
-
Formula Weight393.53
-
Molecular FormulaC25H31NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC[C@H](C2=CC=C(OC)C(OC3CCCC3)=C2)C[C@H]1CC4=CC=CC(C)=C4
-
Chemical Name(3S,5S)-5-(3-(cyclopentyloxy)-4-methoxyphenyl)-3-(3-methylbenzyl)piperidin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Peters M, et al. Neuropsychopharmacology. 2014 Dec;39(13):2938-48.
2. MacDonald E, et al. Neurorehabil Neural Repair. 2007 Nov-Dec;21(6):486-96.
3. Bourtchouladze R, et al. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10518-22.
2. MacDonald E, et al. Neurorehabil Neural Repair. 2007 Nov-Dec;21(6):486-96.
3. Bourtchouladze R, et al. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10518-22.
molnova catalog
related products
-
CHF6001
A novel, highly potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC50 of 0.026 nM.
-
Roflumilast
Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor.
-
Ensifentrine
Ensifentrine is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
